These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1379 related articles for article (PubMed ID: 19011627)
1. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Yu X; Harden K; Gonzalez LC; Francesco M; Chiang E; Irving B; Tom I; Ivelja S; Refino CJ; Clark H; Eaton D; Grogan JL Nat Immunol; 2009 Jan; 10(1):48-57. PubMed ID: 19011627 [TBL] [Abstract][Full Text] [Related]
2. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells. Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041 [TBL] [Abstract][Full Text] [Related]
3. The TIGIT/CD226 axis regulates human T cell function. Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644 [TBL] [Abstract][Full Text] [Related]
4. TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance. Fu W; Cai R; Ma Z; Li T; Lei C; Zhao J; Hu S Front Immunol; 2021; 12():649135. PubMed ID: 33841433 [TBL] [Abstract][Full Text] [Related]
5. Limited Impact of the Inhibitory Receptor TIGIT on NK and T Cell Responses during Aldridge DL; Phan AT; de Waal Malefyt R; Hunter CA Immunohorizons; 2021 Jun; 5(6):384-394. PubMed ID: 34088852 [TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of polyclonal antibodies against mouse T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory domain by DNA-based immunization. Gao Y; Cui J; He W; Yue J; Yu D; Cai L; Xu H; Yang C; Chen ZK; Zhou H Transplant Proc; 2014; 46(1):260-5. PubMed ID: 24507063 [TBL] [Abstract][Full Text] [Related]
10. Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development. Foks AC; Ran IA; Frodermann V; Bot I; van Santbrink PJ; Kuiper J; van Puijvelde GH PLoS One; 2013; 8(12):e83134. PubMed ID: 24376654 [TBL] [Abstract][Full Text] [Related]
11. DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cell-initiated antigen-specific T-cell responses. Shi L; Luo K; Xia D; Chen T; Chen G; Jiang Y; Li N; Cao X Blood; 2006 Oct; 108(8):2678-86. PubMed ID: 16794255 [TBL] [Abstract][Full Text] [Related]
12. CD155T/TIGIT Signaling Regulates CD8 He W; Zhang H; Han F; Chen X; Lin R; Wang W; Qiu H; Zhuang Z; Liao Q; Zhang W; Cai Q; Cui Y; Jiang W; Wang H; Ke Z Cancer Res; 2017 Nov; 77(22):6375-6388. PubMed ID: 28883004 [TBL] [Abstract][Full Text] [Related]
13. TIGIT Can Exert Immunosuppressive Effects on CD8+ T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro. Zhang C; Wang Y; Xun X; Wang S; Xiang X; Hu S; Cheng Q; Guo J; Li Z; Zhu J J Immunother; 2020 Oct; 43(8):236-243. PubMed ID: 32804915 [TBL] [Abstract][Full Text] [Related]
14. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. Latour S; Tanaka H; Demeure C; Mateo V; Rubio M; Brown EJ; Maliszewski C; Lindberg FP; Oldenborg A; Ullrich A; Delespesse G; Sarfati M J Immunol; 2001 Sep; 167(5):2547-54. PubMed ID: 11509594 [TBL] [Abstract][Full Text] [Related]
15. Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Liu S; Zhang H; Li M; Hu D; Li C; Ge B; Jin B; Fan Z Cell Death Differ; 2013 Mar; 20(3):456-64. PubMed ID: 23154388 [TBL] [Abstract][Full Text] [Related]
16. TIGIT-Fc Promotes Antitumor Immunity. Shen X; Fu W; Wei Y; Zhu J; Yu Y; Lei C; Zhao J; Hu S Cancer Immunol Res; 2021 Sep; 9(9):1088-1097. PubMed ID: 34244300 [TBL] [Abstract][Full Text] [Related]
17. Computer-aided design of PVR mutants with enhanced binding affinity to TIGIT. Zhou X; Du J; Zhou X; Niu X; Li W; Chen C; Lv S; Wu A; Gou S; Sun Y; Zhai W; Qiu L; Qi Y; Zhao W; Gao Y Cell Commun Signal; 2021 Feb; 19(1):12. PubMed ID: 33557880 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice. Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969 [TBL] [Abstract][Full Text] [Related]
19. TgMab-2: An Anti-human T Cell Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif Domain Monoclonal Antibody for Immunocytochemistry. Saito M; Suzuki H; Kaneko MK; Kato Y Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):157-162. PubMed ID: 35736625 [TBL] [Abstract][Full Text] [Related]
20. Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering. Stengel KF; Harden-Bowles K; Yu X; Rouge L; Yin J; Comps-Agrar L; Wiesmann C; Bazan JF; Eaton DL; Grogan JL Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5399-404. PubMed ID: 22421438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]